Amgen (AMGN) Operating Expenses (2009 - 2026)

Amgen's Operating Expenses history runs 18 years deep, the most recent figure standing at $6.0 billion for Q1 2026.

• In Q1 2026, Operating Expenses fell 14.62% year-over-year to $6.0 billion; the TTM figure through Mar 2026 stood at $26.7 billion (changed 0.11% YoY), while the FY2025 annual figure was $27.7 billion, up 5.75% from the prior year.
• Operating Expenses was $6.0 billion for Q1 2026 at Amgen, down from $7.1 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $7.1 billion in Q4 2025 to a low of $3.7 billion in Q1 2022.
• Historically, Operating Expenses has averaged $5.7 billion across 5 years, with a median of $6.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses retreated 22.46% in 2022, then soared 54.3% in 2024.
• A 5-year view of Operating Expenses shows it stood at $4.6 billion in 2022, then jumped by 50.25% to $6.9 billion in 2023, then slipped by 2.17% to $6.8 billion in 2024, then grew by 5.48% to $7.1 billion in 2025, then fell by 16.71% to $6.0 billion in 2026.
• The last three Operating Expenses figures came in at $6.0 billion (Q1 2026), $7.1 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.